IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

The photolithographic performance of the single-component non-chemically amplified positive-tone i-line photoresist was investigated in detail and half-pitch (hp) 50 nm line and space (L/S) patterns ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...

AML = Acute myeloid leukemia ... and cord blood have improved dramatically and approach those achieved with human-leukocyte-antigen-identical sibling donors. Significant questions remain regarding ...

Eligible patients included adults with AML or MDS, a Karnofsky performance status ≥60%, and age ≥50 years or a hematopoietic cell transplantation comorbidity index score >2. Compared with ...

The first patient with relapsed/refractory acute myeloid leukemia has received ... the genomic loci encoding T-cell receptors (TCR) and beta-2 microglobulin, which eliminates the surface expression of ...

The current standard first-line treatment regimen for ... and provide building blocks for continued cell division. As such, it is a natural target for intervention in AML, and several studies have ...

Researchers at Columbia University have developed an AI method capable of predicting gene activity in any human ... cell and how the cell performs its functions. “Previous models have been trained on ...